Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium

N Patel1, N Kamath, C E Smith

  • 1Department of Anesthesiology, Case Western Reserve University, Cleveland, Ohio 44109, USA.

Abstract

Insights

Divided dose mivacurium is not recommended for 90-second tracheal intubation when coughing is unacceptable. Rocuronium provided similar intubating conditions with less post-intubation coughing and faster neuromuscular recovery.

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Neuromuscular blocking agents are crucial for endotracheal intubation.
  • Mivacurium and rocuronium are commonly used non-depolarizing neuromuscular blockers.

Purpose of the Study:

  • To compare tracheal intubating conditions and neuromuscular blocking characteristics of divided dose mivacurium versus single dose rocuronium.

Main Methods:

  • A randomized study of 32 patients undergoing elective surgery.
  • Anesthesia induced with propofol and maintained with infusion.
  • Patients received either divided dose mivacurium or single dose rocuronium.
  • Tracheal intubation assessed 90 seconds post-initial dose; neuromuscular function monitored via EMG.

Main Results:

  • Both mivacurium and rocuronium provided good-to-excellent intubating conditions in all patients.
  • Mivacurium group had significantly more coughing and bucking post-intubation (10/16 vs 3/16).
  • Neuromuscular function recovery was faster with mivacurium (10% recovery at 20 min) than rocuronium (10% recovery at 45 min).

Conclusions:

  • Divided dose mivacurium is not recommended for 90-second tracheal intubation if coughing and bucking are unacceptable.
  • Rocuronium offers comparable intubating conditions with a lower incidence of adverse airway reflexes.

Related Concept Videos

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...